Impacting lipid disorders through personalised healthcare
3' education - Feb. 2, 2016 - VBWG, Orlando - Daniel J. Rader, M.D.Video navigation menu
FH - a common single-gene disorder 00:15
Efforts of the FH Foundation to identify patients with FH 00:46
'Personalisable' aspects of FH - biomarkers, medicines 01:29
The discovery of PCSK9-inhibitors 01:58
Share this page with your colleagues and friends: